Your cart is currently empty.
If you’re exploring GLP-1 weight loss treatments, you’ve likely come across two big names: Zepbound and Wegovy. Both are powerful tools in the fight against obesity—but they aren’t exactly the same.
This post breaks down how they compare in real-world use, results, side effects, and affordability—so you can decide which one works best for your goals.
What Are Zepbound and Wegovy?
- Wegovy is a brand of semaglutide, approved for chronic weight management. It’s a once-weekly injection that mimics a natural hormone to reduce appetite and slow digestion.
- Zepbound is the weight loss version of tirzepatide, a newer GLP-1 + GIP receptor agonist that offers dual hormone targeting for stronger metabolic effects.
Both medications are FDA-approved for weight loss in adults with obesity or those who are overweight with related health conditions.
Which Works Faster?
Zepbound tends to act faster and result in more weight loss.
In clinical trials:
- Patients on Zepbound lost 15–21% of body weight over time
- Patients on Wegovy lost around 10–15%
That said, individual results vary—and some people respond better to semaglutide (Wegovy) than tirzepatide (Zepbound).
Side Effects: What to Expect
Both meds may cause:
- Nausea
- Constipation or diarrhea
- Fatigue
- Appetite suppression
Zepbound’s dual-action mechanism can lead to stronger appetite control, but also more intense nausea for some users, especially during dose escalation.
If you’re sensitive to GI side effects, Wegovy may feel gentler in the beginning.
Price and Access Without Insurance
This is where online telehealth really changes the game.
At traditional pharmacies:
- Wegovy and Zepbound cost $1,300+ per month without insurance
With Meya, you can access compounded GLP-1 medications (including semaglutide and tirzepatide) for just $196/month—no insurance, no pharmacy delays.
So Which One Is Better?
Choose Zepbound if you want:
- Faster weight loss results
- Dual hormone targeting (GLP-1 + GIP)
- More metabolic support
Choose Wegovy if you prefer:
- A longer-established medication
- Fewer side effects early on
- A semaglutide-only option
Either way, both are clinically proven and work best with consistency and lifestyle support.
Conclusion: Two Powerful Tools, One Affordable Path
Whether you choose Zepbound or Wegovy, the key is access—and consistency.
With affordable telehealth options, you don’t have to wait for insurance approval or pay $1,300/month.
Want real GLP-1 treatment without the high cost? Start with Meya for just $196/month.
